Aloe-Emodin Overcomes Anti-Cancer Drug Resistance to Temozolomide and Prevents Colony Formation and Migration in Primary Human Glioblastoma Cell Lines NULU and ZAR

Molecules. 2023 Aug 11;28(16):6024. doi: 10.3390/molecules28166024.

Abstract

Glioblastoma, the most dangerous and aggressive type of CNS tumor, appears resistant to many chemotherapy drugs. In the patient-derived glioma cell lines NULU and ZAR, which exhibit drug-resistant phenotypes, we investigated the effect of combined AE (Aloe-emodin) and TMZ (temozolomide) and found a significant additive inhibitory effect on cell growth and a promising cytotoxic effect on both cell lines compared to treatment with single agents. We also examined the effect of combined AE and TMZ treatment on the drug-resistance protein MGMT. The results suggest that using AE combined with traditional drugs restores drug resistance in both primary resistant cell lines (NULU and ZAR). Furthermore, migration assays and scratch tests showed that the combined use of AE and TMZ can slow down the colony formation and migration of glioblastoma cells. These convincing results suggest that AE could be a natural adjuvant agent to potentiate the effects of traditional drugs (TMZ) and overcome drug resistance in glioblastoma cells.

Keywords: MGMT; aloe-emodin (AE); apoptosis; autophagy; glioblastoma (GBM); temozolomide (TMZ).

MeSH terms

  • Aloe*
  • Cell Line
  • Emodin*
  • Glioblastoma* / drug therapy
  • Humans
  • Temozolomide / pharmacology

Substances

  • Temozolomide
  • Emodin
  • aloe emodin

Grants and funding

This research was funded by the Italian Ministry of Health with Ricerca Corrente, and the APC was funded by I.R.C.C.S I.N.M. Neuromed. This work was supported by the Italian Ministry of Health with Ricerca Corrente.